JP1684696S - - Google Patents

Info

Publication number
JP1684696S
JP1684696S JPD2020-18823F JP2020018823F JP1684696S JP 1684696 S JP1684696 S JP 1684696S JP 2020018823 F JP2020018823 F JP 2020018823F JP 1684696 S JP1684696 S JP 1684696S
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JPD2020-18823F
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JPD2020-18823F priority Critical patent/JP1684696S/ja
Priority to US29/771,665 priority patent/USD968430S1/en
Application granted granted Critical
Publication of JP1684696S publication Critical patent/JP1684696S/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JPD2020-18823F 2020-09-04 2020-09-04 Active JP1684696S (Direct)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JPD2020-18823F JP1684696S (Direct) 2020-09-04 2020-09-04
US29/771,665 USD968430S1 (en) 2020-09-04 2021-02-24 Display screen or portion thereof with graphical user interface

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JPD2020-18823F JP1684696S (Direct) 2020-09-04 2020-09-04

Publications (1)

Publication Number Publication Date
JP1684696S true JP1684696S (Direct) 2021-05-10

Family

ID=75802164

Family Applications (1)

Application Number Title Priority Date Filing Date
JPD2020-18823F Active JP1684696S (Direct) 2020-09-04 2020-09-04

Country Status (2)

Country Link
US (1) USD968430S1 (Direct)
JP (1) JP1684696S (Direct)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD1094396S1 (en) * 2022-09-19 2025-09-23 Schlumberger Technology Corporation Display screen or portion thereof with a graphical user interface
JP1770639S (ja) * 2023-08-21 2024-05-17 搬送ロボット操作用画像

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD501483S1 (en) * 2004-02-20 2005-02-01 Microsoft Corporation Portion of a display screen
USD552618S1 (en) * 2005-07-14 2007-10-09 Brother Industries, Ltd. Graphic user interface for handheld terminal
USD638440S1 (en) * 2010-02-13 2011-05-24 Microsoft Corporation Display screen with a group of icons
USD725672S1 (en) * 2011-11-29 2015-03-31 Sony Corporation Portion of display panel or screen with an icon
USD753687S1 (en) * 2013-06-09 2016-04-12 Apple Inc. Display screen or portion thereof with graphical user interface
USD761275S1 (en) * 2014-08-29 2016-07-12 Samsung Electronics Co., Ltd. Display screen or portion thereof with animated graphical user interface
USD786907S1 (en) * 2015-09-08 2017-05-16 Apple Inc. Display screen or portion thereof with graphical user interface
JP1588677S (Direct) * 2016-09-08 2017-10-23
USD870749S1 (en) * 2018-01-04 2019-12-24 Samsung Electronics Co., Ltd. Display screen or portion thereof with transitional graphical user interface
USD900839S1 (en) * 2018-01-05 2020-11-03 Samsung Electronics Co., Ltd. Display screen or portion thereof with graphical user interface
JP1632949S (Direct) * 2018-09-27 2019-06-03
USD910683S1 (en) * 2018-12-06 2021-02-16 Samsung Electronics Co., Ltd. Display screen or portion thereof with graphical user interface

Also Published As

Publication number Publication date
USD968430S1 (en) 2022-11-01

Similar Documents

Publication Publication Date Title
BR102021007058A2 (Direct)
BR102020022030A2 (Direct)
AR134288A1 (es) UN PÉPTIDO CÍCLICO PARA ATRAPAR LA INTERLEUCINA-1b
AR134282A1 (es) Compuestos y composiciones farmacéuticas que degradan el regulador de la subfamilia a de la cromatina dependiente de actina asociado a la matriz relacionado con swi / snf
AR134271A1 (es) Variantes de cnp, conjugados y formulaciones de los mismos
AR134276A1 (es) ANTICUERPOS ANTI-MIGIS-a Y MÉTODOS DE USO DE ESTOS
AR134275A1 (es) Anticuerpos cd24
AR134266A1 (es) Métodos para tratar el cáncer utilizando compuestos que inhiben la pkmyt1
AR134264A1 (es) Correctores farmacológicos de rodopsina y sus usos
AR134263A1 (es) Tratamiento de covid persistente con composición de vesículas extracelulares
AR134262A1 (es) Formulación líquida de agente biológico en almacenamiento estable
AR134258A1 (es) Degradadores bcl-xl heterobifuncionales de tetrahidroisoquinolina
AR134257A1 (es) Degradadores bcl-xl heterobifuncionales de tetrahidroisoquinolina
AR134219A1 (es) Derivados de (piperidin-4-il)-1,5-naftiridina y (piperidin-4-il)quinolina sustituidos y usos de los mismos
AR134214A1 (es) Redireccionamiento de cápsides de aav para dirigirlas al sistema nervioso central
AR134215A1 (es) Compuestos de tiazol y métodos de uso
AR134203A1 (es) Compuestos para la degradación de braf mutante
AR134206A1 (es) Degradantes y usos de los mismos
AR134200A1 (es) Combinaciones de herbicida / protector a base de herbicidas de la clase de las amidas de ácido n-(1,3,4-oxadiazol-2-il)fenilcarboxílico quirales y sus sales
AR134198A1 (es) Compuestos de proteasa 1 de procesamiento específico de ubiquitina (usp1)
AR134193A1 (es) Métodos para tratar tumores tenosinoviales de células gigantes
AR134194A1 (es) Nuevos moduladores de nitrato, amonio y potasio en plantas y métodos para usarlos
AR134180A1 (es) Péptidos inmunogénicos de magea1, proteínas de unión que reconocen los péptidos inmunogénicos de magea1 y usos de los mismos
AR134185A1 (es) Anticuerpos anti-receptor de transferrina y usos de estos
AR134176A1 (es) VARIANTES DEL DOMINIO Fc CON UNIÓN MEJORADA AL RECEPTOR Fc